{"result": "(\"entity\"<|>HYPERPHENYLALANINEMIA<|>EVENT<|>Hyperphenylalaninemia is a biochemical phenotype characterized by persistently elevated plasma phenylalanine levels due to metabolic disorders affecting neurotransmitter synthesis.)\n##\n(\"entity\"<|>PHENYLALANINE HYDROXYLASE<|>ORGANIZATION<|>Phenylalanine hydroxylase (PAH) is an enzyme that is crucial for the metabolism of phenylalanine, and its deficiency is the primary cause of hyperphenylalaninemia.)\n##\n(\"entity\"<|>DIHYDROPTERIDINAREDUCTASE<|>ORGANIZATION<|>Dihydropteridine reductase (DHPR) is an enzyme involved in the metabolism of neurotransmitters, and its dysfunction can contribute to hyperphenylalaninemia.)\n##\n(\"entity\"<|>TETRAHYDROBIOPTERIN<|>ORGANIZATION<|>Tetrahydrobiopterin (BH4) is a cofactor necessary for the activity of phenylalanine hydroxylase and is important in the treatment of hyperphenylalaninemia.)\n##\n(\"entity\"<|>SPAIN<|>GEO<|>Spain is a country where special low-phenylalanine diets and commercial formulas for managing phenylketonuria (PKU) are utilized.)\n##\n(\"entity\"<|>CASEN RECORDATI<|>ORGANIZATION<|>Casen Recordati is a commercial brand that produces special formulas for low-phenylalanine diets used in the management of PKU.)\n##\n(\"entity\"<|>MEAD-JOHNSON<|>ORGANIZATION<|>Mead-Johnson is a company that provides various nutritional products, including those for managing phenylketonuria.)\n##\n(\"entity\"<|>MILUPA SA<|>ORGANIZATION<|>Milupa SA is a company that offers specialized dietary products for individuals with phenylketonuria.)\n##\n(\"entity\"<|>NUTRICIA SA<|>ORGANIZATION<|>Nutricia SA is a brand that produces nutritional products, including those for low-phenylalanine diets.)\n##\n(\"entity\"<|>SCIENTIFIC HOSPITAL SUPPLIES<|>ORGANIZATION<|>Scientific Hospital Supplies (SHS) is a supplier of specialized dietary products for managing phenylketonuria.)\n##\n(\"entity\"<|>VITAFLO ESPAÑA<|>ORGANIZATION<|>Vitaflo España is a company that provides specialized formulas for individuals with phenylketonuria.)\n##\n(\"relationship\"<|>PHENYLALANINE HYDROXYLASE<|>HYPERPHENYLALANINEMIA<|>The deficiency of phenylalanine hydroxylase is the primary cause of hyperphenylalaninemia, leading to elevated phenylalanine levels.<|>9)\n##\n(\"relationship\"<|>DIHYDROPTERIDINAREDUCTASE<|>HYPERPHENYLALANINEMIA<|>Dihydropteridine reductase dysfunction can contribute to the development of hyperphenylalaninemia due to its role in neurotransmitter metabolism.<|>7)\n##\n(\"relationship\"<|>TETRAHYDROBIOPTERIN<|>HYPERPHENYLALANINEMIA<|>Tetrahydrobiopterin is a cofactor for phenylalanine hydroxylase, and its deficiency can lead to hyperphenylalaninemia.<|>8)\n##\n(\"relationship\"<|>SPAIN<|>CASEN RECORDATI<|>Casen Recordati provides specialized dietary products in Spain for managing phenylketonuria, which is prevalent in the country.<|>6)\n##\n(\"relationship\"<|>SPAIN<|>MEAD-JOHNSON<|>Mead-Johnson supplies nutritional products in Spain, including those for individuals with phenylketonuria.<|>6)\n##\n(\"relationship\"<|>SPAIN<|>MILUPA SA<|>Milupa SA offers specialized dietary products in Spain for managing phenylketonuria.<|>6)\n##\n(\"relationship\"<|>SPAIN<|>NUTRICIA SA<|>Nutricia SA provides nutritional products in Spain, including those for low-phenylalanine diets.<|>6)\n##\n(\"relationship\"<|>SPAIN<|>SCIENTIFIC HOSPITAL SUPPLIES<|>Scientific Hospital Supplies supplies specialized dietary products in Spain for managing phenylketonuria.<|>6)\n##\n(\"relationship\"<|>SPAIN<|>VITAFLO ESPAÑA<|>Vitaflo España offers specialized formulas in Spain for individuals with phenylketonuria.<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: enzima, la DHPR. Estos pacientes mani-\n                                                                            fiestan síntomas de afectación neurológica debi-\n2.1.    Consideraciones generales                                           do al déficit de neurotransmisores y no suelen\n   La hiperfenilalaninemia es un término genérico que                       responder al tratamiento dietético.\nse otorga a un fenotipo bioquímico en el que existe un                2.3.   Tratamiento dietético general\naumento persistente de la concentración plasmática de\nfenilalanina (Phe) causado por trastornos de la hidroxi-                 El tratamiento de la PKU es para toda la vida y se\nlación hepática1. Dichos trastornos pueden implicar                   basa en la restricción de alimentos con contenido en\ntanto a la enzima fenilalanin-hidroxilasa (PAH), a su                 fenilalanina.\ncofactor, la coenzima tetrahidrobiopterina (BH4) como                 dietético en el pronóstico de la enfermedad4.\n                                                                                                                   Hay que destacar la importancia del buen control\na la dihidropteridinareductasa (DHPR).\n   La principal causa de hiperfenilalninemia es el defec-                Actualmente existen nuevas opciones terapéuticas\nto de actividad de PAH.                                               (véase en el apartado 2.6).\n   La herencia de esta entidad es autosómica recesiva y                  Las bases del tratamiento dietético son las si-\nsu incidencia global es de 1:4000/21195 recién naci-                  guientes:\ndos dependiendo de la zona geográfica2.\n   El gen PAH está localizado en el cromosoma 12                         a. Limitar la ingesta de fenilalanina en la dieta, con\n(12q22-24), habiéndose descrito hasta el momento                            el objetivo de conseguir unos niveles de fenilalani-\nmás de 400 mutaciones, algunas de ellas mutaciones                          na en sangre inferiores a 6 mg/dl (360                μmol/l).\nde novo3.                                                                   Como en muchas ocasiones no se dispone de la\n   La mutación más frecuente en el sur de Europa es la                      cantidad de Phe que contiene un determinado\nIVS10.                                                                      alimento, se estima la cantidad de Phe mediante\n---\n                                                                  Tema 18.      Soporte nutricional en metabolopatías de los aminoácidos…                      307\nLactantesInfantilesAdultos\n                      el contenido en proteínas naturales de alto valor                              día, en función de la edad, mínimo 5 tomas/día\n                      biológico (PNAVB)14 (tablas 2 y 3).                                            (tabla 1).\n                      El manejo de la Phe en la dieta PKU se suele hacer                             En los últimos años ha aumentado la variedad de\n                      mediante un sistema de porciones o intercam-                                   estos preparados; estos presentan distintas carac-\n                      bios,    lo  más    común      suelen     ser  porciones      de               terísticas, lo cual permite una mayor adaptación a\n                      50 mg, cantidad equivalente a 1 g de PNAVB y                                   las necesidades del paciente.\n                      facilita mucho la confección de la dieta. Pero en                              Las fórmulas especiales utilizadas en la actualidad\n                      aquellos casos en los que la tolerancia es menor                               para dietas de bajo contenido en Phe en España\n                      puede interesar usar porciones de 10 mg.                                       incluyen varias casas comerciales: Casen Recorda-\n                      Lo recomendable es que el aporte de Phe en la                                  ti, Mead-Jhonson, Milupa SA, Nutricia SA, Scien-\n                      dieta se haga de la manera más homogénea posi-                                 tific Hospital Supplies (SHS) y Vitaflo España.\n                      ble a fin de evitar posibles descompensaciones en                              Disponen de distintos productos para las diferen-\n                      los niveles de Phe en sangre.                                                  tes edades13.\n                   b. Aportar el resto de aminoácidos en forma de pre-                               La elección de una fórmula u otra va a depender\n                      parados comerciales exentos de Phe: 1,5-3 g/kg                                 de distintos factores, aparte de los factores más\n\n\n\n                Tabla 1.    Listado de preparados comerciales para fenilcetonuria.\n\n\n\n                        Presentación\n                                              Casen Fleet PKU1\n                                              Casen Fleet PKU Gel (> 6 meses)\n                        Polvo                 Mead-Johnson Phenyl-free 1\n                                              PKU Anamix Infant (0-12 meses)\n                                              PKU Anamix Junior (1-10 años)\n                                                                                                                                                   Con alta\n                                                             Sin lípidos                                    Con lípidos                        concentración\n                                                                                                                                                de proteínas\n                                              Casen Fleet PKU Gel                            Mead-Johnson Phenyl-free 2\n                        Polvo                 Vitaflo PKU Gel                                Casen Fleet PKU Star\n                                                                                             Casen Fleet PKU Star monodosis\n                                              Vitaflo PKU Cooler 10 (> 3 años)\n                        Líquido               Vitaflo PKU Cooler 15 (>\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}